GRIGUOLO, GAIA

GRIGUOLO, GAIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 77 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis 2015 Griguolo G. + TUMORI - -
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 2022 Griguolo, GaiaTosi, AnnaDieci, Maria VittoriaVentura, AnnaveraBottosso, MicheleMiglietta, FedericaFassan, MatteoConte, PierFrancoRosato, AntonioGuarneri, Valentina + NEURO-ONCOLOGY - -
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 2020 Guarneri, ValentinaGriguolo, GaiaDieci, Maria VUrso, LoredanaMiglietta, FedericaConte, Pierfranco + THE LANCET ONCOLOGY - -
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + CLINICAL CANCER RESEARCH - -
A systematic review of contemporary phase I trials in patients with lymphoma 2022 Griguolo, G + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 2019 Dieci M. V.TSVETKOVA, VASSILENAGriguolo G.Miglietta F.MANTIERO, MARACumerlato E.Giorgi C. A.Giarratano T.FAGGIONI, GIULIA MARTINAVernaci G.Menichetti A.MIORANZA, ELEONORAFREZZINI, SIMONAOrvieto E.Guarneri V. + FRONTIERS IN ONCOLOGY - -
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer 2023 Guarneri, VGriguolo, G + ANNALS OF ONCOLOGY - -
BET inhibitors as potential anticancer agents 2015 Griguolo, G. + DRUGS OF THE FUTURE - -
Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome 2017 GRIGUOLO, GAIADIECI, MARIA VITTORIAMIORANZA, ELEONORATASCA, GIULIAMILITE, NICOLAMiglietta, FedericaCONTE, PIERFRANCOGUARNERI, VALENTINA + JOURNAL OF NEURO-ONCOLOGY - -
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors 2020 Dieci M. V.Miglietta F.Griguolo G.Guarneri V. CANCER TREATMENT REVIEWS - -
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis 2019 Vernaci G.Dieci M. V.MANFRIN, SILVIAMantiero M.Menichetti A.Griguolo G.Miglietta F.Di Liso E.Conte P.Guarneri V. + THE BREAST - -
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 2019 S. FrezziniT. GiarratanoG. GriguoloL. PiccinE. MioranzaA. MenichettiF. MigliettaE. GenovesiE. CumerlatoM. BottossoG. VernaciM. V. Dieci + TUMORI - -
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy 2023 Edoardo Vincenzo SavarinoIlaria PatuzziFabiana ZingoneFederica MigliettaGaia GriguoloMatteo FassanValentina GuarneriMaria Vittoria Dieci + THE ONCOLOGIST - -
Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all? 2017 MIGLIETTA, FEDERICADieci, M. V.GRIGUOLO, GAIAGUARNERI, VALENTINACONTE, PIERFRANCO CANCER TREATMENT REVIEWS - -
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology 2018 Griguolo, GaiaDieci, Maria VittoriaMiglietta, FedericaConte, PierfrancoGuarneri, Valentina + THE ONCOLOGIST - -
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study 2019 Guarneri, VDieci, M VUrso, LGriguolo, GConte, P F + ANNALS OF ONCOLOGY - -
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review 2022 Griguolo, GaiaGuarneri, Valentina + CANCERS - -
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer 2022 Guarneri, ValentinaGriguolo, GaiaDieci, Maria VittoriaConte, Pierfranco + EBIOMEDICINE - -
Erbb2 mrna expression and response to ado-trastuzumab emtansine (T-dm1) in her2-positive breast cancer 2020 Griguolo G.Tsvetkova V.Giarratano T.Dieci M. V.Conte P.Guarneri V. + CANCERS - -
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 2021 Urso L.Vernaci G.Fassan M.Zulato E.Faggioni G.Menichetti A.Di Liso E.Griguolo G.Conte P.Indraccolo S.Guarneri V.Dieci M. V. + FRONTIERS IN ONCOLOGY - -